These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38812506)

  • 1. The prognostic implications and tumor-promoting functions of CHSY3 in gastric cancer.
    Wang H; Zhang J; Wei Z; Chen S; Zheng J; Li Y
    Front Immunol; 2024; 15():1364979. PubMed ID: 38812506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHSY3 promotes proliferation and migration in gastric cancer and is associated with immune infiltration.
    Huang X; Liu Y; Qian C; Shen Q; Wu M; Zhu B; Feng Y
    J Transl Med; 2023 Jul; 21(1):474. PubMed ID: 37461041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated TUBA1A Might Indicate the Clinical Outcomes of Patients with Gastric Cancer, Being Associated with the Infiltration of Macrophages in the Tumor Immune Microenvironment.
    Wang D; Jiao Z; Ji Y; Zhang S
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):509-522. PubMed ID: 33331338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cuproptosis-related gene DLAT is a biomarker of the prognosis and immune microenvironment of gastric cancer and affects the invasion and migration of cells.
    Peng Y; Shi R; Yang S; Zhu J
    Cancer Med; 2024 Jul; 13(14):e70012. PubMed ID: 39031012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.
    Wang J; Liu X; Chu HJ; Li N; Huang LY; Chen J
    Technol Cancer Res Treat; 2021; 20():15330338211045510. PubMed ID: 34617858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of TRPV1 ion channels in the suppression of gastric cancer development.
    Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
    J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
    Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
    Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
    Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers.
    Cho SY; Oh Y; Jeong EM; Park S; Lee D; Wang X; Zeng Q; Qin H; Hu F; Gong H; Liu X; Zhang G; Na D; Lee J; Chae J; Suh YS; Kong SH; Lee HJ; Kim JI; Park H; Zhang C; Yang HK; Lee C
    Exp Mol Med; 2020 May; 52(5):854-864. PubMed ID: 32467608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 13. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
    He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
    Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells.
    Miao L; Qi J; Zhao Q; Wu QN; Wei DL; Wei XL; Liu J; Chen J; Zeng ZL; Ju HQ; Luo HY; Xu RH
    Theranostics; 2020; 10(2):498-515. PubMed ID: 31903134
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Li X; Fan Y; Zhang Y; Wang Y; Zhao M; Tang M; Li H; Mi J; Geng Z; Wang Z; Su F
    Front Genet; 2022; 13():876588. PubMed ID: 35571047
    [No Abstract]   [Full Text] [Related]  

  • 16. Vinculin promotes gastric cancer proliferation and migration and predicts poor prognosis in patients with gastric cancer.
    Zhang M; Liu P; Xu F; He Y; Xie X; Jiang X
    J Cell Biochem; 2019 Aug; 120(8):14107-14115. PubMed ID: 30989694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer.
    Sun M; Jin FY; Xia R; Kong R; Li JH; Xu TP; Liu YW; Zhang EB; Liu XH; De W
    BMC Cancer; 2014 May; 14():319. PubMed ID: 24884417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2 macrophage-derived extracellular vesicles promote gastric cancer progression via a microRNA-130b-3p/MLL3/GRHL2 signaling cascade.
    Zhang Y; Meng W; Yue P; Li X
    J Exp Clin Cancer Res; 2020 Jul; 39(1):134. PubMed ID: 32660626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.